Table 1.
db/db mice |
DIO mice |
|||||
---|---|---|---|---|---|---|
Parameter | Control | Ad5E4ORF1 | Ad36E4ORF1 | Control | Ad5E4ORF1 | Ad36E4ORF1 |
Serum glucose (mg/dL) | 470 ± 61.2 | 424 ± 51.6 | 292 ± 32.4* | 225.9 ± 16.0 | 182.3 ± 11.3* | 172.8 ± 14.8* |
Serum insulin (ng/mL) | 17.7 ± 4.2 | 5.0 ± 1.4* | 5.5 ± 2.1* | 1.73 ± 0.22 | 1.01 ± 0.28 | 0.37 ± 0.21*** |
Serum cholesterol (mg/dL) | 80.5 ± 9.4 | 83.2 ± 8.4 | 106.4 ± 9.8 | 176.9 ± 18.3 | 139.6 ± 12.2 | 168.4 ± 15.5 |
Serum triglycerides (mg/dL) | 159.1 ± 36.9 | 102.8 ± 9.4 | 79.0 ± 9.4 | 99.8 ± 9.4 | 92.7 ± 10.3 | 59.7 ± 7.3** |
Serum NEFA (mEQ/L) | 0.45 ± 0.05 | 0.44 ± 0.06 | 0.41 ± 0.03 | 0.36 ± 0.03 | 0.31 ± 0.04 | 0.30 ± 0.04 |
Serum leptin (ng/mL) | 49.3 ± 4.3 | 43.8 ± 4.3 | 51.2 ± 5.6 | 20.0 ± 1.0 | 14.2 ± 1.4** | 3.8 ± 1.0*** |
Serum adiponectin (μg/mL) | 6.4 ± 0.6 | 5.4 ± 0.5 | 4.4 ± 0.4* | 12.0 ± 0.6 | 10.4 ± 0.4 | 8.2 ± 0.6*** |
Liver cholesterol (mg/g) | 10.3 ± 1.3 | 13.5 ± 1.1 | 13.3 ± 1.0 | 15.6 ± 3.0 | 14.8 ± 3.1 | 16.1 ± 2.4 |
Liver triglycerides (mg/g) | 149.1 ± 9.4 | 173.4 ± 9.4 | 186.6 ± 9.4 | 113.9 ± 38.5 | 136.8 ± 39.3 | 262.5 ± 21.8** |
Liver NEFA (mEQ/g) | 0.24 ± 0.02 | 0.20 ± 0.01 | 0.21 ± 0.3 | 0.16 ± 0.01 | 0.16 ± 0.01 | 0.15 ± 0.01 |
Liver glycogen (mg/g) | 7.49 ± 0.73 | 5.94 ± 0.15 | 6.20 ± 0.28 | 5.40 ± 0.38 | 4.54 ± 0.34 | 2.86 ± 0.10** |
Data are mean ± SEM. n = 8 per group in db/db experiment. n = 8 control, 8 Ad5E4ORF1, and 9 Ad36E4ORF1 in DIO experiment. NEFA, nonesterified fatty acid.
*P < 0.05,
**P < 0.01,
***P < 0.001 vs. control.